• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症正电子发射断层扫描(PET)和荧光成像(FI)的双探针

Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer.

作者信息

Yuen Richard, West Frederick G, Wuest Frank

机构信息

Department of Chemistry, University of Alberta, Edmonton, AB T6G 2G2, Canada.

Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada.

出版信息

Pharmaceutics. 2022 Mar 15;14(3):645. doi: 10.3390/pharmaceutics14030645.

DOI:10.3390/pharmaceutics14030645
PMID:35336019
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8952779/
Abstract

Dual probes that possess positron emission tomography (PET) and fluorescence imaging (FI) capabilities are precision medicine tools that can be used to improve patient care and outcomes. Detecting tumor lesions using PET, an extremely sensitive technique, coupled with fluorescence-guided surgical resection of said tumor lesions can maximize the removal of cancerous tissue. The development of novel molecular probes is important for targeting different biomarkers as every individual case of cancer has different characteristics. This short review will discuss some aspects of dual PET/FI probes and explore the recently reported examples.

摘要

具有正电子发射断层扫描(PET)和荧光成像(FI)功能的双探针是精准医疗工具,可用于改善患者护理和治疗效果。使用PET(一种极其灵敏的技术)检测肿瘤病变,再结合对所述肿瘤病变进行荧光引导手术切除,可最大限度地切除癌组织。开发新型分子探针对于靶向不同生物标志物很重要,因为每例癌症都有不同特征。这篇简短综述将讨论双PET/FI探针的一些方面,并探讨最近报道的实例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/dd11bc8f30d5/pharmaceutics-14-00645-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/a5e43ed312d0/pharmaceutics-14-00645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/b940d4bc59e7/pharmaceutics-14-00645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/69a6a2ca4638/pharmaceutics-14-00645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/86be55865815/pharmaceutics-14-00645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/c511ace7cace/pharmaceutics-14-00645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e02a850d6e54/pharmaceutics-14-00645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/b5c4e24fed39/pharmaceutics-14-00645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/21be400d4fc2/pharmaceutics-14-00645-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/7a18d36a1379/pharmaceutics-14-00645-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/d5db1ebc926a/pharmaceutics-14-00645-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e49b5c5ba39c/pharmaceutics-14-00645-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/cde159b01743/pharmaceutics-14-00645-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/2c1c4be223c6/pharmaceutics-14-00645-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e900e277a917/pharmaceutics-14-00645-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e288e5812b51/pharmaceutics-14-00645-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/c05053c3de5f/pharmaceutics-14-00645-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/dd11bc8f30d5/pharmaceutics-14-00645-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/a5e43ed312d0/pharmaceutics-14-00645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/b940d4bc59e7/pharmaceutics-14-00645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/69a6a2ca4638/pharmaceutics-14-00645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/86be55865815/pharmaceutics-14-00645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/c511ace7cace/pharmaceutics-14-00645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e02a850d6e54/pharmaceutics-14-00645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/b5c4e24fed39/pharmaceutics-14-00645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/21be400d4fc2/pharmaceutics-14-00645-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/7a18d36a1379/pharmaceutics-14-00645-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/d5db1ebc926a/pharmaceutics-14-00645-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e49b5c5ba39c/pharmaceutics-14-00645-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/cde159b01743/pharmaceutics-14-00645-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/2c1c4be223c6/pharmaceutics-14-00645-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e900e277a917/pharmaceutics-14-00645-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/e288e5812b51/pharmaceutics-14-00645-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/c05053c3de5f/pharmaceutics-14-00645-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/226e/8952779/dd11bc8f30d5/pharmaceutics-14-00645-g017.jpg

相似文献

1
Dual Probes for Positron Emission Tomography (PET) and Fluorescence Imaging (FI) of Cancer.用于癌症正电子发射断层扫描(PET)和荧光成像(FI)的双探针
Pharmaceutics. 2022 Mar 15;14(3):645. doi: 10.3390/pharmaceutics14030645.
2
Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.作为纳米生物技术多模态探针的协同整合纳米颗粒
Acc Chem Res. 2008 Dec;41(12):1630-40. doi: 10.1021/ar800045c.
3
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
4
Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).设计、合成及评价正电子发射断层扫描/荧光双模式成像探针用于靶向易化葡萄糖转运蛋白 1(GLUT1)。
Org Biomol Chem. 2021 Apr 14;19(14):3241-3254. doi: 10.1039/d1ob00199j. Epub 2021 Mar 24.
5
Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology.双正电子发射断层扫描(PET)与近红外荧光成像探针作为肿瘤成像工具
AJR Am J Roentgenol. 2016 Aug;207(2):266-73. doi: 10.2214/AJR.16.16181. Epub 2016 May 25.
6
PSMA-11-Derived Dual-Labeled PSMA Inhibitors for Preoperative PET Imaging and Precise Fluorescence-Guided Surgery of Prostate Cancer.PSMA-11 衍生的双标记 PSMA 抑制剂用于前列腺癌的术前 PET 成像和精确荧光引导手术。
J Nucl Med. 2018 Apr;59(4):639-645. doi: 10.2967/jnumed.117.201293. Epub 2017 Nov 30.
7
Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review.根治性前列腺切除术后生化复发的男性患者行挽救性放疗前使用正电子发射断层扫描/计算机断层扫描的情况及其影响:范围综述。
Eur Urol Oncol. 2021 Jun;4(3):339-355. doi: 10.1016/j.euo.2021.01.007. Epub 2021 Feb 24.
8
[Positron emission tomography: basic principle and radionuclides/probes for metabolic/functional analysis].[正电子发射断层扫描:代谢/功能分析的基本原理及放射性核素/探针]
Rinsho Byori. 2007 Jul;55(7):630-8.
9
Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.抗前列腺干细胞抗原半胱氨酸二联体用于胰腺癌的免疫 PET/近红外荧光双模态成像。
J Nucl Med. 2018 Sep;59(9):1398-1405. doi: 10.2967/jnumed.117.207332. Epub 2018 Mar 30.
10
Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.正电子发射断层扫描/计算机断层扫描联合 18F-氟代胆碱可改善肝细胞癌患者的肿瘤分期和治疗分配。
J Hepatol. 2018 Aug;69(2):336-344. doi: 10.1016/j.jhep.2018.02.018. Epub 2018 Mar 6.

引用本文的文献

1
Nanoagent-Mediated Photothermal Therapy: From Delivery System Design to Synergistic Theranostic Applications.纳米制剂介导的光热疗法:从递送系统设计到协同诊疗应用
Int J Nanomedicine. 2025 May 29;20:6891-6927. doi: 10.2147/IJN.S522736. eCollection 2025.
2
Dual-Labeled Small Peptides in Cancer Imaging and Fluorescence-Guided Surgery: Progress and Future Perspectives.癌症成像与荧光引导手术中的双标记小肽:进展与未来展望
Pharmaceuticals (Basel). 2025 Jan 22;18(2):143. doi: 10.3390/ph18020143.
3
Peptide Multifunctionalization via Modular Construction of Trans-ABC Porphyrin on Resin.

本文引用的文献

1
Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET.用于正电子发射断层显像(PET)的放射性核素标记示踪剂对肿瘤缺氧的成像
Front Oncol. 2021 Sep 7;11:731503. doi: 10.3389/fonc.2021.731503. eCollection 2021.
2
Design, synthesis, and evaluation of positron emission tomography/fluorescence dual imaging probes for targeting facilitated glucose transporter 1 (GLUT1).设计、合成及评价正电子发射断层扫描/荧光双模式成像探针用于靶向易化葡萄糖转运蛋白 1(GLUT1)。
Org Biomol Chem. 2021 Apr 14;19(14):3241-3254. doi: 10.1039/d1ob00199j. Epub 2021 Mar 24.
3
Small Molecule, Multimodal, [F]-PET and Fluorescence Imaging Agent Targeting Prostate-Specific Membrane Antigen: First-in-Human Study.
通过在树脂上对反式ABC卟啉进行模块化构建实现肽的多功能化。
Adv Sci (Weinh). 2025 Apr;12(14):e2409771. doi: 10.1002/advs.202409771. Epub 2025 Feb 19.
4
Translocator Protein 18 kDa (TSPO): A Promising Molecular Target for Image-Guided Surgery of Solid Cancers.18 kDa转位蛋白(TSPO):实体癌图像引导手术中有前景的分子靶点。
Adv Pharm Bull. 2024 Mar;14(1):86-104. doi: 10.34172/apb.2024.015. Epub 2023 Oct 14.
5
Fluorescence-Based Mono- and Multimodal Imaging for In Vivo Tracking of Mesenchymal Stem Cells.基于荧光的间充质干细胞活体示踪的单模态和多模态成像。
Biomolecules. 2023 Dec 13;13(12):1787. doi: 10.3390/biom13121787.
6
New hybrid radio-fluorescent probes [I]-BPF-01 and [I]-BPF-02 for visualisation of cancer cells: Synthesis and preliminary in vitro and ex vivo evaluations.用于可视化癌细胞的新型放射性荧光杂交探针[I]-BPF-01和[I]-BPF-02:合成及初步体外和离体评估。
Heliyon. 2023 Oct 5;9(10):e20710. doi: 10.1016/j.heliyon.2023.e20710. eCollection 2023 Oct.
小分子、多模式、[F]-PET 和荧光成像剂靶向前列腺特异性膜抗原:首例人体研究。
Clin Genitourin Cancer. 2021 Oct;19(5):405-416. doi: 10.1016/j.clgc.2021.03.011. Epub 2021 Mar 19.
4
Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.镓-PSMA-11 NDA 获批:新颖且成功的学术合作。
J Nucl Med. 2021 Feb;62(2):149-155. doi: 10.2967/jnumed.120.260455. Epub 2020 Dec 18.
5
High yield cyclotron production of a novel La theranostic pair for nuclear medicine.高产回旋加速器生产新型镧放射性药物用于核医学
Sci Rep. 2020 Dec 17;10(1):22203. doi: 10.1038/s41598-020-79198-x.
6
Evaluation of [N]ammonia positron emission tomography as a potential method for quantifying glutamine synthetase activity in the human brain.评估[N]氨正电子发射断层扫描作为定量人类大脑中谷氨酰胺合成酶活性的潜在方法。
EJNMMI Res. 2020 Dec 3;10(1):146. doi: 10.1186/s13550-020-00731-0.
7
Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC).在放射性药物研究委员会(RDRC)批准下使用55种正电子发射断层扫描(PET)放射性示踪剂。
EJNMMI Radiopharm Chem. 2020 Nov 11;5(1):24. doi: 10.1186/s41181-020-00110-z.
8
Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye.用于用螯合剂和近红外荧光花菁染料进行化学选择性和高效生物分子修饰的混合多模态成像合成子
Pharmaceuticals (Basel). 2020 Sep 16;13(9):250. doi: 10.3390/ph13090250.
9
Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*.用于癌症可视化的功能杂化分子:与多模态分子成像探针结合的 PESIN 同源二聚体,用于正电子发射断层扫描和光学成像:适合跟踪 GRPR 阳性恶性组织*。
Chemistry. 2020 Dec 9;26(69):16349-16356. doi: 10.1002/chem.202002386. Epub 2020 Oct 28.
10
Development of a fluorine-18 radiolabelled fluorescent chalcone: evaluated for detecting glycogen.一种氟-18放射性标记的荧光查尔酮的研发:用于糖原检测的评估。
EJNMMI Radiopharm Chem. 2020 Jun 23;5(1):17. doi: 10.1186/s41181-020-00098-6.